RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data (Q33966102)

30 July 2017

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data (English)

1 reference

30 July 2017

1 reference

5

1 reference

30 July 2017

Bálint Balázs

4

0 references

author name string

Balázs Győrffy

1

1 reference

30 July 2017

Zsombor Benke

2

1 reference

30 July 2017

András Lánczky

3

1 reference

30 July 2017

József Timár

6

1 reference

30 July 2017

Reinhold Schäfer

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

16 July 2011

1 reference

Breast Cancer Research and Treatment

30 July 2017

1 reference

30 July 2017

132

1 reference

30 July 2017

1025-1034

1 reference

30 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1676-y

30 July 2017

0 references

cites work

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Quality assessment of Affymetrix GeneChip data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Integrated gene expression profile predicts prognosis of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1676-Y

10.1007/S10549-011-1676-Y

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference